Artificial Intelligence
The global market for Laboratory Information System (LIS) is forecast to reach US$2. 4 billion by 2025
New York, Sept. 29, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Laboratory Information Systems (LIS) Industry” – https://www.reportlinker.com/p05957217/?utm_source=GNW
The age of epidemics is here with infectious diseases, especially zoonotic diseases expected to emerge and re-emerge as globalization and growing population encroach into wild animal environments & habitats. Laboratory diagnosis is an essential element of communicable disease surveillance & epidemic management. LIS, in this regard, helps in making labs more efficient & productive by automating sample handling; reducing time spent on processes; auto-authorization of reports; elimination of human error; reduced costs; and easy scalability of operations. Functionality of LIS today is much beyond the original sample management purpose. An LIS today does assay data management, data analysis, data mining and also ELN (Electronic Laboratory Notebook) integration. Different vendors offer different LISs depending on industry needs. There are different systems for clinical labs, R&D labs and labs in the food & beverage industry. There are also different deployment types for LIS
remote, cloud and on-premise. On-premise LIS is purchased, installed and operated on servers owned by labs themselves. They are located on actual site in the laboratory. There are however, disadvantages associated with on-premise software solutions. Deploying and managing one is expensive and time-consuming. The solutions also place strain on seamless sharing of data (scalability potential). A cloud solution or a cloud SaaS model enables users to subscribe to one without having to own a system permanently for LIS. Cloud SaaS LIS requires only secure connection for making the license work. Complete support for lab information management is provided by the SaaS vendor. In a remotely hosted LIS, the software is deployed and hosted at a data center. Users are relieved of IT infrastructure management tasks.
An LIS in order to be effective must be capable of tracking and managing samples, reports and queries and create sufficient visibility among different laboratory equipment as well as inventory. These are the basic functionalities of an LIS and any other capability would be bonus. These can include ERP, advanced data analysis capability and any other functionality that is industry-specific. The basic functions/ features of an LIS however are sample management, workflow management, inventory management and reporting. With LIS, risks of contamination, mislabeling, and misplacement are reduced. An LIS automates and streamlines laboratory workflows. It assigns tests and tasks to researchers and defines and standardizes workflow processes. Essential points of testing, at all stages of workflow, are created by an LIS. Inventory management is another key functionality of LIS. Lab personnel are required to track samples accurately. Not just samples, but also instruments used in the labs must be accurately tracked. Use of manual resources for managing inventory can prove to be expensive. LIS fully automates the process and is comparatively cheaper. Another important benefit with LIS is its ability of reporting. The system can automate, maintain and dispose test reports in a timely manner.
Read the full report: https://www.reportlinker.com/p05957217/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
A Prelude to Laboratory Information Systems (LIS)
Functions of an Effective LIS
Global Laboratory Information Systems Market to Witness Rapid
Growth
Standalone LIS Holds Major Share
Services Segment Dominates the LIS Market, Software to Witness
Higher Growth during the Forecast Period
On-Premise LIS Holds Major Share Due to Customization Benefits
Cloud-based LIS Model to Grow in Prominence due to Many
Benefits Offered over Traditional, On-Premise Models
US Holds Clear Edge over Other Regions, Asia-Pacific to Exhibit
Fastest Growth
Artificial Intelligence: The Future of LIMS
RECENT MARKET ACTIVITY
2. FOCUS ON SELECT PLAYERS
Orchard Software Corporation (US)
Sunquest Information Systems, Inc. (US)
Cerner Corporation (US)
CompuGroup Medical AG (Germany)
Meditech (US)
SCC Soft Computer (US)
3. MARKET TRENDS & DRIVERS
Burgeoning Population and Rising Incidence of Chronic Diseases –
A Key Market Driver for LIS
Fatalities by Heart Conditions – Estimated Percentage Breakdown
for Cardiovascular Disease, Ischemic Heart Disease, Stroke,
and Others
Worldwide Cancer Incidence: Number of New Cancer Cases
Diagnosed for 2012, 2018 & 2040
Number of New Cancer Cases Reported (in Thousands) by Cancer
Type: 2018
Rising Diabetes Prevalence Presents Opportunity for iPSCs
Market: Number of Adults (20-79) with Diabetes (in Millions)
by Region for 2017 and 2045
Aging Demographics Add to the Global Burden of Chronic
Diseases, Presenting Opportunities for Laboratory Information
System/LIS market
Expanding Elderly Population Worldwide: Breakdown of Number of
People Aged 65+ Years in Million by Geographic Region for the
Years 2019 and 2030
Growing Adoption of Laboratory Automation Drives the Need for LIS
Rise of Laboratory 4.0 to Spur the Adoption of LIS
Laboratory Information Systems Gain Traction amidst Growing
Need to Enhance Workflow Efficiencies and Reduce Costs
Healthy Trajectory in Genomics Research Favors Market Growth
Market Stands to Gain from Growing Proteomics Research Volumes
Global Proteomics Market Sales in US$ Million for the Years
2019 and 2024
Improving Healthcare Expenditure to Turbo Charge Future Growth
of the Market
World Healthcare Spending & Growth (in US$ Trillion) and % Real
GDP Growth for the Years 2012 through 2018
Need to Improve Diagnostics Accuracy
Increasing Popularity of Enterprise LIS
Rise in Consolidation of Healthcare Providers Creates Need for
Robust and Comprehensive LIS
Growing Emphasis on Personalized Medicine to Support Growth
Rise in Investment in R&D Activity to Spur Growth
Shortage of Trained Professionals Hinders Adoption Rate
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Laboratory
Information Systems (LIS) by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027
Table 2: World Historic Review for Laboratory Information
Systems (LIS) by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019
Table 3: World 15-Year Perspective for Laboratory Information
Systems (LIS) by Geographic Region – Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Standalone by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027
Table 5: World Historic Review for Standalone by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 6: World 15-Year Perspective for Standalone by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 7: World Current & Future Analysis for Integrated by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027
Table 8: World Historic Review for Integrated by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 9: World 15-Year Perspective for Integrated by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 10: World Current & Future Analysis for On-Premise by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027
Table 11: World Historic Review for On-Premise by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 12: World 15-Year Perspective for On-Premise by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Web-Based by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027
Table 14: World Historic Review for Web-Based by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 15: World 15-Year Perspective for Web-Based by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 16: World Current & Future Analysis for Cloud-Based by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027
Table 17: World Historic Review for Cloud-Based by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 18: World 15-Year Perspective for Cloud-Based by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Services by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027
Table 20: World Historic Review for Services by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 21: World 15-Year Perspective for Services by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 22: World Current & Future Analysis for Software by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027
Table 23: World Historic Review for Software by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 24: World 15-Year Perspective for Software by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 25: World Current & Future Analysis for Hospital
Laboratories by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027
Table 26: World Historic Review for Hospital Laboratories by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 27: World 15-Year Perspective for Hospital Laboratories
by Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for Independent
Laboratories by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027
Table 29: World Historic Review for Independent Laboratories by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 30: World 15-Year Perspective for Independent
Laboratories by Geographic Region – Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027
Table 31: World Current & Future Analysis for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027
Table 32: World Historic Review for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 33: World 15-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Table 34: USA Current & Future Analysis for Laboratory
Information Systems (LIS) by Product – Standalone and
Integrated – Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027
Table 35: USA Historic Review for Laboratory Information
Systems (LIS) by Product – Standalone and Integrated Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 36: USA 15-Year Perspective for Laboratory Information
Systems (LIS) by Product – Percentage Breakdown of Value Sales
for Standalone and Integrated for the Years 2012, 2020 & 2027
Table 37: USA Current & Future Analysis for Laboratory
Information Systems (LIS) by Delivery – On-Premise, Web-Based
and Cloud-Based – Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027
Table 38: USA Historic Review for Laboratory Information
Systems (LIS) by Delivery – On-Premise, Web-Based and
Cloud-Based Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 39: USA 15-Year Perspective for Laboratory Information
Systems (LIS) by Delivery – Percentage Breakdown of Value Sales
for On-Premise, Web-Based and Cloud-Based for the Years 2012,
2020 & 2027
Table 40: USA Current & Future Analysis for Laboratory
Information Systems (LIS) by Component – Services and Software –
Independent Analysis of Annual Sales in US$ for the Years
2020 through 2027
Table 41: USA Historic Review for Laboratory Information
Systems (LIS) by Component – Services and Software Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 42: USA 15-Year Perspective for Laboratory Information
Systems (LIS) by Component – Percentage Breakdown of Value
Sales for Services and Software for the Years 2012, 2020 & 2027
Table 43: USA Current & Future Analysis for Laboratory
Information Systems (LIS) by End-Use – Hospital Laboratories,
Independent Laboratories and Other End-Uses – Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
Table 44: USA Historic Review for Laboratory Information
Systems (LIS) by End-Use – Hospital Laboratories, Independent
Laboratories and Other End-Uses Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 45: USA 15-Year Perspective for Laboratory Information
Systems (LIS) by End-Use – Percentage Breakdown of Value Sales
for Hospital Laboratories, Independent Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027
CANADA
Table 46: Canada Current & Future Analysis for Laboratory
Information Systems (LIS) by Product – Standalone and
Integrated – Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027
Table 47: Canada Historic Review for Laboratory Information
Systems (LIS) by Product – Standalone and Integrated Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 48: Canada 15-Year Perspective for Laboratory Information
Systems (LIS) by Product – Percentage Breakdown of Value Sales
for Standalone and Integrated for the Years 2012, 2020 & 2027
Table 49: Canada Current & Future Analysis for Laboratory
Information Systems (LIS) by Delivery – On-Premise, Web-Based
and Cloud-Based – Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027
Table 50: Canada Historic Review for Laboratory Information
Systems (LIS) by Delivery – On-Premise, Web-Based and
Cloud-Based Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 51: Canada 15-Year Perspective for Laboratory Information
Systems (LIS) by Delivery – Percentage Breakdown of Value Sales
for On-Premise, Web-Based and Cloud-Based for the Years 2012,
2020 & 2027
Table 52: Canada Current & Future Analysis for Laboratory
Information Systems (LIS) by Component – Services and Software –
Independent Analysis of Annual Sales in US$ for the Years
2020 through 2027
Table 53: Canada Historic Review for Laboratory Information
Systems (LIS) by Component – Services and Software Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 54: Canada 15-Year Perspective for Laboratory Information
Systems (LIS) by Component – Percentage Breakdown of Value
Sales for Services and Software for the Years 2012, 2020 & 2027
Table 55: Canada Current & Future Analysis for Laboratory
Information Systems (LIS) by End-Use – Hospital Laboratories,
Independent Laboratories and Other End-Uses – Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
Table 56: Canada Historic Review for Laboratory Information
Systems (LIS) by End-Use – Hospital Laboratories, Independent
Laboratories and Other End-Uses Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 57: Canada 15-Year Perspective for Laboratory Information
Systems (LIS) by End-Use – Percentage Breakdown of Value Sales
for Hospital Laboratories, Independent Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027
JAPAN
Table 58: Japan Current & Future Analysis for Laboratory
Information Systems (LIS) by Product – Standalone and
Integrated – Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027
Table 59: Japan Historic Review for Laboratory Information
Systems (LIS) by Product – Standalone and Integrated Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 60: Japan 15-Year Perspective for Laboratory Information
Systems (LIS) by Product – Percentage Breakdown of Value Sales
for Standalone and Integrated for the Years 2012, 2020 & 2027
Table 61: Japan Current & Future Analysis for Laboratory
Information Systems (LIS) by Delivery – On-Premise, Web-Based
and Cloud-Based – Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027
Table 62: Japan Historic Review for Laboratory Information
Systems (LIS) by Delivery – On-Premise, Web-Based and
Cloud-Based Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 63: Japan 15-Year Perspective for Laboratory Information
Systems (LIS) by Delivery – Percentage Breakdown of Value Sales
for On-Premise, Web-Based and Cloud-Based for the Years 2012,
2020 & 2027
Table 64: Japan Current & Future Analysis for Laboratory
Information Systems (LIS) by Component – Services and Software –
Independent Analysis of Annual Sales in US$ for the Years
2020 through 2027
Table 65: Japan Historic Review for Laboratory Information
Systems (LIS) by Component – Services and Software Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 66: Japan 15-Year Perspective for Laboratory Information
Systems (LIS) by Component – Percentage Breakdown of Value
Sales for Services and Software for the Years 2012, 2020 & 2027
Table 67: Japan Current & Future Analysis for Laboratory
Information Systems (LIS) by End-Use – Hospital Laboratories,
Independent Laboratories and Other End-Uses – Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
Table 68: Japan Historic Review for Laboratory Information
Systems (LIS) by End-Use – Hospital Laboratories, Independent
Laboratories and Other End-Uses Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 69: Japan 15-Year Perspective for Laboratory Information
Systems (LIS) by End-Use – Percentage Breakdown of Value Sales
for Hospital Laboratories, Independent Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027
CHINA
Table 70: China Current & Future Analysis for Laboratory
Information Systems (LIS) by Product – Standalone and
Integrated – Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027
Table 71: China Historic Review for Laboratory Information
Systems (LIS) by Product – Standalone and Integrated Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 72: China 15-Year Perspective for Laboratory Information
Systems (LIS) by Product – Percentage Breakdown of Value Sales
for Standalone and Integrated for the Years 2012, 2020 & 2027
Table 73: China Current & Future Analysis for Laboratory
Information Systems (LIS) by Delivery – On-Premise, Web-Based
and Cloud-Based – Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027
Table 74: China Historic Review for Laboratory Information
Systems (LIS) by Delivery – On-Premise, Web-Based and
Cloud-Based Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 75: China 15-Year Perspective for Laboratory Information
Systems (LIS) by Delivery – Percentage Breakdown of Value Sales
for On-Premise, Web-Based and Cloud-Based for the Years 2012,
2020 & 2027
Table 76: China Current & Future Analysis for Laboratory
Information Systems (LIS) by Component – Services and Software –
Independent Analysis of Annual Sales in US$ for the Years
2020 through 2027
Table 77: China Historic Review for Laboratory Information
Systems (LIS) by Component – Services and Software Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 78: China 15-Year Perspective for Laboratory Information
Systems (LIS) by Component – Percentage Breakdown of Value
Sales for Services and Software for the Years 2012, 2020 & 2027
Table 79: China Current & Future Analysis for Laboratory
Information Systems (LIS) by End-Use – Hospital Laboratories,
Independent Laboratories and Other End-Uses – Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
Table 80: China Historic Review for Laboratory Information
Systems (LIS) by End-Use – Hospital Laboratories, Independent
Laboratories and Other End-Uses Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 81: China 15-Year Perspective for Laboratory Information
Systems (LIS) by End-Use – Percentage Breakdown of Value Sales
for Hospital Laboratories, Independent Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027
EUROPE
Table 82: Europe Current & Future Analysis for Laboratory
Information Systems (LIS) by Geographic Region – France,
Germany, Italy, UK and Rest of Europe Markets – Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027
Table 83: Europe Historic Review for Laboratory Information
Systems (LIS) by Geographic Region – France, Germany, Italy, UK
and Rest of Europe Markets – Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019
Table 84: Europe 15-Year Perspective for Laboratory Information
Systems (LIS) by Geographic Region – Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2020 & 2027
Table 85: Europe Current & Future Analysis for Laboratory
Information Systems (LIS) by Product – Standalone and
Integrated – Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027
Table 86: Europe Historic Review for Laboratory Information
Systems (LIS) by Product – Standalone and Integrated Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 87: Europe 15-Year Perspective for Laboratory Information
Systems (LIS) by Product – Percentage Breakdown of Value Sales
for Standalone and Integrated for the Years 2012, 2020 & 2027
Table 88: Europe Current & Future Analysis for Laboratory
Information Systems (LIS) by Delivery – On-Premise, Web-Based
and Cloud-Based – Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027
Table 89: Europe Historic Review for Laboratory Information
Systems (LIS) by Delivery – On-Premise, Web-Based and
Cloud-Based Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 90: Europe 15-Year Perspective for Laboratory Information
Systems (LIS) by Delivery – Percentage Breakdown of Value Sales
for On-Premise, Web-Based and Cloud-Based for the Years 2012,
2020 & 2027
Table 91: Europe Current & Future Analysis for Laboratory
Information Systems (LIS) by Component – Services and Software –
Independent Analysis of Annual Sales in US$ for the Years
2020 through 2027
Table 92: Europe Historic Review for Laboratory Information
Systems (LIS) by Component – Services and Software Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 93: Europe 15-Year Perspective for Laboratory Information
Systems (LIS) by Component – Percentage Breakdown of Value
Sales for Services and Software for the Years 2012, 2020 & 2027
Table 94: Europe Current & Future Analysis for Laboratory
Information Systems (LIS) by End-Use – Hospital Laboratories,
Independent Laboratories and Other End-Uses – Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
Table 95: Europe Historic Review for Laboratory Information
Systems (LIS) by End-Use – Hospital Laboratories, Independent
Laboratories and Other End-Uses Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 96: Europe 15-Year Perspective for Laboratory Information
Systems (LIS) by End-Use – Percentage Breakdown of Value Sales
for Hospital Laboratories, Independent Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027
FRANCE
Table 97: France Current & Future Analysis for Laboratory
Information Systems (LIS) by Product – Standalone and
Integrated – Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027
Table 98: France Historic Review for Laboratory Information
Systems (LIS) by Product – Standalone and Integrated Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019m
Table 99: France 15-Year Perspective for Laboratory Information
Systems (LIS) by Product – Percentage Breakdown of Value Sales
for Standalone and Integrated for the Years 2012, 2020 & 2027
Table 100: France Current & Future Analysis for Laboratory
Information Systems (LIS) by Delivery – On-Premise, Web-Based
and Cloud-Based – Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027
Table 101: France Historic Review for Laboratory Information
Systems (LIS) by Delivery – On-Premise, Web-Based and
Cloud-Based Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 102: France 15-Year Perspective for Laboratory
Information Systems (LIS) by Delivery – Percentage Breakdown of
Value Sales for On-Premise, Web-Based and Cloud-Based for the
Years 2012, 2020 & 2027
Table 103: France Current & Future Analysis for Laboratory
Information Systems (LIS) by Component – Services and Software –
Independent Analysis of Annual Sales in US$ for the Years
2020 through 2027
Table 104: France Historic Review for Laboratory Information
Systems (LIS) by Component – Services and Software Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 105: France 15-Year Perspective for Laboratory
Information Systems (LIS) by Component – Percentage Breakdown
of Value Sales for Services and Software for the Years 2012,
2020 & 2027
Table 106: France Current & Future Analysis for Laboratory
Information Systems (LIS) by End-Use – Hospital Laboratories,
Independent Laboratories and Other End-Uses – Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
Table 107: France Historic Review for Laboratory Information
Systems (LIS) by End-Use – Hospital Laboratories, Independent
Laboratories and Other End-Uses Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 108: France 15-Year Perspective for Laboratory
Information Systems (LIS) by End-Use – Percentage Breakdown of
Value Sales for Hospital Laboratories, Independent Laboratories
and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
Table 109: Germany Current & Future Analysis for Laboratory
Information Systems (LIS) by Product – Standalone and
Integrated – Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027
Table 110: Germany Historic Review for Laboratory Information
Systems (LIS) by Product – Standalone and Integrated Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 111: Germany 15-Year Perspective for Laboratory
Information Systems (LIS) by Product – Percentage Breakdown of
Value Sales for Standalone and Integrated for the Years 2012,
2020 & 2027
Table 112: Germany Current & Future Analysis for Laboratory
Information Systems (LIS) by Delivery – On-Premise, Web-Based
and Cloud-Based – Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027
Table 113: Germany Historic Review for Laboratory Information
Systems (LIS) by Delivery – On-Premise, Web-Based and
Cloud-Based Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 114: Germany 15-Year Perspective for Laboratory
Information Systems (LIS) by Delivery – Percentage Breakdown of
Value Sales for On-Premise, Web-Based and Cloud-Based for the
Years 2012, 2020 & 2027
Table 115: Germany Current & Future Analysis for Laboratory
Information Systems (LIS) by Component – Services and Software –
Independent Analysis of Annual Sales in US$ for the Years
2020 through 2027
Table 116: Germany Historic Review for Laboratory Information
Systems (LIS) by Component – Services and Software Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 117: Germany 15-Year Perspective for Laboratory
Information Systems (LIS) by Component – Percentage Breakdown
of Value Sales for Services and Software for the Years 2012,
2020 & 2027
Table 118: Germany Current & Future Analysis for Laboratory
Information Systems (LIS) by End-Use – Hospital Laboratories,
Independent Laboratories and Other End-Uses – Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
Table 119: Germany Historic Review for Laboratory Information
Systems (LIS) by End-Use – Hospital Laboratories, Independent
Laboratories and Other End-Uses Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 120: Germany 15-Year Perspective for Laboratory
Information Systems (LIS) by End-Use – Percentage Breakdown of
Value Sales for Hospital Laboratories, Independent Laboratories
and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
Table 121: Italy Current & Future Analysis for Laboratory
Information Systems (LIS) by Product – Standalone and
Integrated – Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027
Table 122: Italy Historic Review for Laboratory Information
Systems (LIS) by Product – Standalone and Integrated Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 123: Italy 15-Year Perspective for Laboratory Information
Systems (LIS) by Product – Percentage Breakdown of Value Sales
for Standalone and Integrated for the Years 2012, 2020 & 2027
Table 124: Italy Current & Future Analysis for Laboratory
Information Systems (LIS) by Delivery – On-Premise, Web-Based
and Cloud-Based – Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027
Table 125: Italy Historic Review for Laboratory Information
Systems (LIS) by Delivery – On-Premise, Web-Based and
Cloud-Based Markets – Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019
Table 126: Italy 15-Year Perspective for Laboratory Information
Systems (LIS) by Delivery – Percentage Breakdown of Value Sales
for On-Premise, Web-Based and Cloud-Based for the Years 2012,
2020 & 2027
Table 127: Italy Current & Future Analysis for Laboratory
Information Systems (LIS) by Component – Services and Software –
Independent Analysis of Annual Sales in US$ for the Years
2020 through 2027
Table 128: Italy Historic Review for Laboratory Information
Systems (LIS) by Component – Services and Software Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 129: Italy 15-Year Perspective for Laboratory Information
Systems (LIS) by Component – Percentage Breakdown of Value
Sales for Services and Software for the Years 2012, 2020 & 2027
Table 130: Italy Current & Future Analysis for Laboratory
Information Systems (LIS) by End-Use – Hospital Laboratories,
Independent Laboratories and Other End-Uses – Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
Table 131: Italy Historic Review for Laboratory Information
Systems (LIS) by End-Use – Hospital Laboratories, Independent
Laboratories and Other End-Uses Markets – Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019
Table 132: Italy 15-Year Perspective for Laboratory Information
Systems (LIS) by End-Use – Percentage Breakdown of Value Sales
for Hospital Laboratories, Independent Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 133: UK Current & Future Analysis for Laboratory
Information Systems (LIS) by Product – Standalone and
Integrated – Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027
Table 134: UK Historic Review for Laboratory Information
Systems (LIS) by Product – Standalone and Integrated Markets –
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019
Table 135: UK 15-Year Perspective for Laboratory Information
Systems (LIS) by Product – Percentage Breakdown of Value Sales
for Standalone and Integrated for the Years 2012, 2020 & 2027
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05957217/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Artificial Intelligence
Netcompany secures high-profile digital transformation contract with HM Revenue & Customs (HMRC)
Netcompany wins one of four new build contracts for HMRC. The European IT services company will focus on modernising core digital customer services for HMRC’s Customer Services Group. The contract term is three years with options for two, one-year extensions. The estimated contract spend is £120–£135m over the course of the 5-year term.
LONDON, May 13, 2024 /PRNewswire/ — Netcompany has won a significant new build contract for His Majesty’s Revenue and Customs (HMRC). It will provide digital transformation services to HMRC’s Customer Services Group (CSG), including the Customer Compliance Group (CCG). Netcompany was selected following a competitive procurement process.
“We are proud and honoured to be selected to bring our expertise and knowledge to bear in helping enable HMRC’s digitalisation journey,” says André Rogaczewski, CEO, Netcompany. “Improving citizen experience through responsible digitalisation of public services is a core part of our DNA. Through this partnership, Netcompany looks forward to working with HMRC to help realise their digital transformation aspirations, resulting in both better customer services and value to the taxpayer.”
The contract Netcompany has been awarded to deliver aims to simplify access and management of citizens’ tax affairs, through one personalised digital account. The contract was won through the first phase of competitions run under Crown Commercial Service’s (CCS) Digital and Legacy Application Services (DALAS) framework, Lot 2a – Large Scale Digital, Integration and Development Services.
About Netcompany
Founded in Denmark in 2000, Netcompany is a fast-growing, multinational company, working across 10 countries, with a team of more than 7,700 skilled professionals, who drive sustainable digitisation, consistently improving outcomes for our customers and citizens. Netcompany provides mission-critical IT solutions for societal and business needs, aiding our clients in their digital evolution towards a more efficient and sustainable future. Netcompany UK has extensive experience of working across the public sector, including NHS England, Ministry of Defence, Home Office, HMRC, Department for Education, Department for Environment, Food & Rural Affairs, as well as extensive private sector experience.
About Crown Commercial Service
Crown Commercial Service (CCS) is an Executive Agency of the Cabinet Office, supporting the public sector to achieve maximum commercial value when procuring common goods and services.
To find out more about CCS, visit: www.crowncommercial.gov.ukFollow us on Twitter: @gov_procurementLinkedIn: www.linkedin.com/company/2827044
Logo: https://mma.prnewswire.com/media/2410706/Netcompany_Logo.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/netcompany-secures-high-profile-digital-transformation-contract-with-hm-revenue–customs-hmrc-302143350.html
Artificial Intelligence
Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)
STOCKHOLM, May 13, 2024 /PRNewswire/ — Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) (“SciBase” or the “Company”). The general meeting resolved in accordance with the proposals presented in the notice to attend the meeting (which is available on the Company’s website (www.scibase.com)).
Amendment of the articles of association
The general meeting resolved, in accordance with the board of directors’ three proposals, to amend §§ 4-5 of the articles of association, entailing:
that the articles of association shall be amended so that the share capital shall be not less than SEK 10,065,000 and not more than SEK 40,260,000 and that the number of shares shall be not less than 201,300,000 and not more than 805,200,000,that the articles of association shall be amended so that the share capital shall be not less than SEK 10,780,000 and not more than SEK 43,120,000 and that the number of shares shall be not less than 215,600,000 and not more than 862,400,000, andthat the articles of association shall be amended so that the share capital shall be not less than SEK 11,500,000 and not more than SEK 46,000,000 and that the number of shares shall be not less than 230,000,000 and not more than 920,000,000.The general meeting further resolved, in a accordance with the board of directors’ proposal, to authorize the board of directors to register with the Swedish Companies Registration Office the above resolution to amend the Articles of Association, the limits of which for the minimum and maximum number of shares in the Company are consistent with the total number of shares in the Company after the rights issue announced on 5 April 2024 and the directed issues of units that the board of directors resolved upon on 5 April 2024 (that were conditional upon the subsequent approval of the general meeting).
Directed issues
The general meeting resolved, in accordance with the board of directors’ proposal, to approve the resolution made by the board of directors on 5 April 2024, on a new issue of a maximum of 74,136,510 units to Ribbskottet AB, Per Olof Ejendal AB, Kåre Gilstring, Robert Molander, MLJK Konsult AB, Klintemar Konsult AB, Jesper Hoiland, Fredrik Mattsson, Stefan Hansson, Theodor Invest AB, Ulti AB, Van Herk Investments B.V., Morningside Group AB, Viktor Drvota and Eric Terhaerdt. The subscription price for each unit is SEK 0.42, corresponding to a subscription price of SEK 0.42 per share. Warrants of series TO 2 are issued free of charge. The issue results in an increase in the number of shares in the Company of a maximum of 74,136,510 shares, entailing a maximum increase of the share capital of SEK 3,706,825.50, and a new issue of a maximum of 370,682,550 warrants of series TO 2 entitling to subscription of 370,682,550 shares in the Company, whereby the share capital may increase by an additional maximum of SEK 18,534,127.50 if all issued warrants of series TO 2 are exercised. In total, the share capital may increase by a maximum of SEK 22,240,953.00.
The general meeting further resolved in accordance with the board of directors’ proposal to approve the resolution made by the board of directors on 5 April 2024, on a new issue of a maximum of 3,755,259 units to Matt Leavitt. The subscription price for each unit is SEK 0.42, corresponding to a subscription price of SEK 0.42 per share. Warrants of series TO 2 are issued free of charge. The issue results in an increase in the number of shares in the Company of a maximum of 3 755 259 shares, entailing a maximum increase of the share capital of SEK 187,762.95, and a new issue of a maximum of 18,776,295 warrants of series TO 2 entitling to subscription of 18,776,295 shares in the Company, whereby the share capital may increase by an additional maximum of SEK 938,814.75 if all issued warrants of series TO 2 are exercised. In total, the share capital may increase by a maximum of SEK 1,126,577.70.
For additional information, please contact:Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected] Advisor (CA):Vator SecuritiesTel: +46 8 580 065 99Email: [email protected]
About SciBase:
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
The Company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at www.scibase.com. All press releases and financial reports can be found here: http://investors.scibase.se/en/pressreleases
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/scibase/r/bulletin-from-the-extraordinary-general-meeting-in-scibase-holding-ab–publ-,c3977529
The following files are available for download:
https://mb.cision.com/Main/12371/3977529/2790414.pdf
SciBase Bulletin EGM
View original content:https://www.prnewswire.co.uk/news-releases/bulletin-from-the-extraordinary-general-meeting-in-scibase-holding-ab-publ-302143337.html
Artificial Intelligence
Experience Abu Dhabi Weixin Mini-Program: Your Gateway to Unforgettable Moments in Abu Dhabi
ABU DHABI, UAE, May 13, 2024 /PRNewswire/ — Prepare for a memorable journey with the new Experience Abu Dhabi Weixin mini-program, brought to you by Experience Abu Dhabi, in partnership with Tencent Cloud.
Weixin is commonly known as ‘WeChat’ outside of China serves over a billion of monthly active users in the Chinese mainland. Tailored for Chinese visitors, the Weixin mini-program is packed with compelling features that range from interactive maps to itinerary planners – everything they would need to plan their Abu Dhabi experience at their fingertips.
The program not only provides Chinese visitors with first-hand official travel information but also specifically addresses their digital travel needs, offering map guidance and Chinese audio commentary services during the travel process.
The program also introduces ‘Khalifa’, a welcoming Emirati character who serves as Abu Dhabi’s first digital ambassador for culture and tourism. Khalifa isn’t just a tour guide, he’s your virtual companion, ready to engage in conversation and answer all visitor questions about Abu Dhabi!
Whether you’re looking for thrilling attractions, world-class restaurants or inspiring activities, Khalifa will provide personalised recommendations and insider tips to enhance your experience.
About Tencent Cloud
Tencent Cloud, one of the world’s leading cloud companies, is committed to creating innovative solutions to resolve real-world issues and enabling digital transformation for smart industries. Through our extensive global infrastructure, Tencent Cloud provides businesses across the globe with stable and secure industry-leading cloud products and services, leveraging technological advancements such as cloud computing, Big Data analytics, AI, IoT, and network security. It is our constant mission to meet the needs of industries across the board, including the fields of gaming, media and entertainment, finance, healthcare, property, retail, travel, and transportation.
About the Department of Culture and Tourism – Abu Dhabi:
The Department of Culture and Tourism – Abu Dhabi (DCT Abu Dhabi) drives the sustainable growth of Abu Dhabi’s culture and tourism sectors and its creative industries, fuelling economic progress and helping to achieve Abu Dhabi’s wider global ambitions.
By working in partnership with the organisations that define the emirate’s position as a leading international destination, DCT Abu Dhabi strives to unite the ecosystem around a shared vision of the emirate’s potential, coordinate effort and investment, deliver innovative solutions, and use the best tools, policies and systems to support the culture and tourism industries.
DCT Abu Dhabi’s vision is defined by the emirate’s people, heritage and landscape. We work to enhance Abu Dhabi’s status as a place of authenticity, innovation, and unparalleled experiences, represented by its living traditions of hospitality, pioneering initiatives and creative thought.
For more information about the Department of Culture and Tourism – Abu Dhabi and the destination, please visit: dct.gov.ae and visitabudhabi.ae
View original content:https://www.prnewswire.co.uk/news-releases/experience-abu-dhabi-weixin-mini-program-your-gateway-to-unforgettable-moments-in-abu-dhabi-302143308.html
-
Artificial Intelligence5 days ago
Körber Pharma and Siemens Take the Lead in ABI Research’s MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive Ranking
-
Artificial Intelligence6 days ago
Solar EV Charging to Bypass the Grid: A US$2.5 Billion Market by 2034, Says IDTechEx
-
Artificial Intelligence5 days ago
New Momentum in Pharma Automation: ArisGlobal’s 2024 Industry Survey Report Highlights Surge in AI-Powered Safety & Regulatory Processes
-
Artificial Intelligence5 days ago
Ness Digital Engineering Acquires Intricity – a New York based company specializing in data strategy, governance, modernization, and monetization
-
Uncategorized5 days ago
Smart Waste Management Market to Reach $8.3 billion by 2032 at 15.6% CAGR: Allied Market Research
-
Artificial Intelligence3 days ago
Sanad Announces Strategic Sale Transaction with CFM Materials, Further Fostering Aviation Industry Collaborations
-
Artificial Intelligence3 days ago
Northern Data Group’s Peak Mining announces new partnership for 28MW of mining, powered by 100% renewable energy
-
Artificial Intelligence6 days ago
Imaging Endpoints Unveils New Initiative with Revolution Endpoints™, an Investment Subsidiary to Accelerate Innovation and Growth